Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. The coronavirus may have ushered in the era of social distancing, but in some ways it has brought the global medical community closer together, even if it’s online rather than in person. This week, there is a Facebook tribute to healthcare
admin
Steady hands and uninterrupted, sharp vision are critical when performing surgery on delicate structures like the brain or hair-thin blood vessels. While surgical cameras have improved what surgeons see during operative procedures, the “steady hand” remains to be enhanced — new surgical technologies, including sophisticated surgeon-guided robotic hands, cannot prevent accidental injuries when operating close
https://www.facebook.com/ArmandoHasudungan Support me: http://www.patreon.com/armando Instagram: http://instagram.com/armandohasudungan Twitter: https://twitter.com/Armando71021105
Reviewed by Emily Henderson, B.Sc.Apr 29 2020 An international study led by Melbourne researchers has discovered nine new genes linked to the most severe type of childhood speech disorder, apraxia. The research analyzed the genetic make-up of 34 affected children and young people, and showed that variations in nine genes likely explained apraxia in 11
Myocardial injury was common but mild and likely non-ischemic among hospitalized COVID-19 patients in New York City, researchers said. Troponin elevations were observed in approximately 40% of 2,736 patients with lab-confirmed SARS-CoV-2 infection who had been admitted to one of five hospitals in the Mount Sinai Health System, according to the group led by Anuradha
Allergy doesn’t always look like allergy — and allergy symptoms can manifest in many different ways. Some experience itchy throat and runny nose. Others know their allergies are peaking when they experience headaches or migraines, and some find that headaches are their only allergy symptom. Though a definitive cause of migraines isn’t totally clear, clinical
The keto diet targets eating 70 percent of healthy fats as part of the regular diet, in order to draw fuel from fat as opposed to glucose. While 20 to 30 percent of the diet consists of protein, about 5 percent to 10 percent is made up of carbohydrates. Meat and dairy are sources of protein and unsaturated
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Hospitalized patients who had advanced COVID-19 with lung involvement and who received the antiviral agent remdesivir (Gilead Sciences) recovered faster than similar patients who received placebo, according to a preliminary data analysis from a US-led randomized, controlled trial. On the basis of
“If by that time we have put into place all of the countermeasures that you need to address this, we should do reasonably well,” Dr. Anthony Fauci said. “If we don’t do that successfully, we could be in for a bad fall and a bad winter.” If states begin lifting restrictions too early, Fauci says
The ILO estimated that people in informal work have experienced a 60% drop in income in the first month of the coronavirus crisis. Rattanakun Thongbun / EyeEm/Getty Images Some 1.6 billion people in informal work, which is nearly half the global workforce, have become at risk of losing income as a result of the coronavirus
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. The broad use of telemedicine has been a bright spot in the COVID-19 response, but the pandemic is also creating significant disruption as some physicians are furloughed and others consider practice changes. A recent survey of physicians conducted by Merritt Hawkins
Ancient Greece has always been an interesting topic to ponder about. Lasting for about 350 years, the ancient Greek civilization was one of the largest and most powerful that the world has ever seen, starting from around 776 BC and ending with the fall of Alexander the Great, per historians. However, although it didn’t last
Print this page DUBLIN and SOUTH SAN FRANCISCO, Calif., April 23, 2020 /PRNewswire/ – Theravance Biopharma, Inc. (NASDAQ: TBPH) (“Theravance Biopharma” or the “Company”), a diversified biopharmaceutical company primarily focused on the discovery, development and commercialization of organ-selective medicines, today announced that the first healthy volunteer has been dosed in a Phase 1 study of TD-0903. TD-0903 is a lung-selective, nebulized Janus
Reviewed by Emily Henderson, B.Sc.Apr 28 2020 Boston Children’s Hospital has launched a two-pronged study of COVID-19 disease among children and youth up to age 25 across the country, with $2.1 million in funding from the Centers for Disease Control and Prevention. The Overcoming COVID-19 study will perform real-time surveillance at more than 35 U.S.
During an uncertain time in our world with the spread of COVID-19 among other viruses, any sign of illness can be nerve wracking. If you’re feeling under the weather, this blog can help you understand the difference in symptoms between COVID-19, the flu, and allergies. While resources like this can help you navigate uncertainty with
The last seven months as Acting CEO of Mental Health Australia has been a rollercoaster of challenges, many rewarding and some, like the bushfires and coronavirus, quite confronting. Above all I would like thank the staff, board, and members for supporting me in the role during this time. From breaking a Guinness World Record on
The spread of COVID-19 has led many industries to quickly change how they operate. Essential businesses have adjusted their everyday practices to accommodate the most vulnerable populations. For many, this means employees work from home, switch to virtual meetings and adjust to a new work-life balance. As you get used to your new workspace, your
Are you feeling overwhelmed when it comes to finding healthy snacks that are also free of the top eight food allergens? Especially in a time where supplies are limited, and going to the grocery store is not as openly available, it can be challenging and frustrating to find healthy, food allergy safe snacks. Making your
A breakthrough treatment providing a long-term cure for children with peanut allergies may soon be widely available. A clinical trial at the Murdoch Children’s Research Institute in Melbourne showed that an experimental peanut-probiotic treatment led to 82 per cent of children who participated successfully being able to eat peanuts. Four years later, 80 per cent
Got Food Allergies? Add Milk To The Worries For Your Meal by Carmen Heredia Rodriguez: [email protected], @caheredia21, Kaiser Health News (KHN) Since her son Matt was an infant, Lynda Mitchell knew he had a milk allergy. She controlled the symptoms by switching his baby formula. But when he was 1, Halloween proved horrifying. While trick-or-treating in
Treatment for Dravet Syndrome Zogenix Announces FDA Extension of Review Period for Fintepla in Dravet Syndrome Print this page EMERYVILLE, Calif., Feb. 27, 2020 (GLOBE NEWSWIRE) — Zogenix, Inc. (NASDAQ: ZGNX), a global pharmaceutical company developing rare disease therapies, today announced that the U.S. Food and Drug Administration (FDA) has extended the review period for
Treatment for Breast cancer FDA Accepts Genentech’s Biologics License Application for Fixed-Dose Subcutaneous Combination of Perjeta And Herceptin For HER2-Positive Breast Cancer Print this page South San Francisco, CA — February 24, 2020 — Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration
ponesimod Treatment for Multiple Sclerosis Janssen Submits Ponesimod New Drug Application to the U.S. FDA for Treatment of Adults with Relapsing Multiple Sclerosis Print this page TITUSVILLE, NEW JERSEY, March 18, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson (Janssen) today announced the submission of a New Drug Application (NDA) to the U.S.
tirbanibulin Treatment for Actinic Keratosis Athenex Announces FDA Acceptance for Filing of U.S. NDA for Tirbanibulin Ointment in Actinic Keratosis Print this page BUFFALO, N.Y., March 09, 2020 (GLOBE NEWSWIRE) – Athenex, Inc. (NASDAQ: ATNX), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of cancer and related conditions, announced today
tanezumab Treatment for Osteoarthritis U.S. FDA Accepts Regulatory Submission for Tanezumab, a Potential First-in-Class Treatment for Patients with Chronic Pain Due to Moderate-to-Severe Osteoarthritis Print this page Monday, March 2, 2020 – Pfizer Inc. (NYSE:PFE) and Eli Lilly and Company (NYSE:LLY) today announced that the U.S. Food and Drug Administration (FDA) accepted for review a
naxitamab Treatment for Neuroblastoma Y-mAbs Announces Submission of Naxitamab Biologics License Application to U.S. FDA Print this page NEW YORK, April 01, 2020 (GLOBE NEWSWIRE) – Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB), a late-stage clinical biopharmaceutical company focused on the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer, today announced that
idecabtagene vicleucel Treatment for Multiple Myeloma Bristol Myers Squibb and bluebird bio Announce Submission of Biologics License Application (BLA) for Anti-BCMA CAR T Cell Therapy Idecabtagene Vicleucel (Ide-cel, bb2121) to FDA Print this page March 31, 2020 — PRINCETON, NJ. & CAMBRIDGE, Mass.–(BUSINESS WIRE)–Bristol Myers Squibb (NYSE: BMY) and bluebird bio, Inc. (Nasdaq: BLUE) today announced the
tivozanib Treatment for Renal Cell Carcinoma AVEO Oncology Announces Submission of New Drug Application to U.S. FDA for Tivozanib in Patients with Relapsed or Refractory Renal Cell Carcinoma Print this page CAMBRIDGE, Mass.–(BUSINESS WIRE)–Mar. 31, 2020– AVEO Oncology (NASDAQ: AVEO) today announced that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA)